Acute Myeloid Leukemia AML Cytogenetics Panel Test sale cost 4100 AED
Liquid Biopsy CfDNA EGFR Test sale cost 4510 AED Liquid Biopsy CfDNA EGFR Test Cost 5,010 د.إ Original price was: 5,010 د.إ.4,510 د.إCurrent price is: 4,510 د.إ.
Myeloproliferative Neoplasia with Eosinophilia Test sale cost 3860 AED Myeloproliferative Neoplasia with Eosinophilia Test Cost 4,290 د.إ Original price was: 4,290 د.إ.3,860 د.إCurrent price is: 3,860 د.إ.
Sale!

Acute Myeloid Leukemia AML Cytogenetics Panel Test Cost

Original price was: 4,550 د.إ.Current price is: 4,100 د.إ.

-10%

The Acute Myeloid Leukemia (AML) Cytogenetics Panel Test is a critical diagnostic tool offered by DNA Labs UAE, designed to identify chromosomal abnormalities associated with AML. This test plays a pivotal role in diagnosing, prognosticating, and guiding the treatment strategies for individuals suspected of having or diagnosed with AML. By analyzing the genetic material of cells from a blood or bone marrow sample, the test can detect various genetic mutations and alterations that are characteristic of AML. These findings can help in determining the specific subtype of AML, predict how the disease will progress, and identify the most effective treatment options. The cost of the AML Cytogenetics Panel Test at DNA Labs UAE is 4100 AED, reflecting the comprehensive analysis and detailed insights it provides, aiding in the personalized management of the disease.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ACUTE MYELOID LEUKEMIA AML CYTOGENETICS PANEL Test

The ACUTE MYELOID LEUKEMIA AML CYTOGENETICS PANEL Test is a diagnostic test offered by DNA Labs UAE. This test is used to analyze the genetic abnormalities present in acute myeloid leukemia (AML) cells. AML is a type of cancer that affects the bone marrow and blood, and genetic abnormalities play a crucial role in its development and progression.

Test Components

  • t (8;21) or LSI ETO/AML1
  • inv (16) (p13q22) or t(16;16) (p13;q22) or CBFB
  • t (15;17) or LSI PML/RARA
  • t(variable;11q23) ; MLL gene breakapart
  • Chromosome analysis, Hematological malignancy

Price

The cost of the ACUTE MYELOID LEUKEMIA AML CYTOGENETICS PANEL Test is AED 4100.0.

Sample Condition

For this test, 8 mL (6 mL min.) whole blood from 2 Green Top (Sodium Heparin) tubes and 4 mL (2 mL min.) Bone Marrow from 1 Green Top (Sodium Heparin) tube are required. The samples should be shipped at 18-22°C and should not be frozen. It is mandatory to fill the Chromosome and FISH analysis Requisition form (Form 17).

Report Delivery

The sample is delivered daily by 4 pm and the report is provided within 4 working days.

Method

The ACUTE MYELOID LEUKEMIA AML CYTOGENETICS PANEL Test uses both FISH and Conventional Karyotyping methods.

Test Type

This test is categorized under Cancer tests.

Doctor

The test is typically referred by Hematologists.

Test Department

The ACUTE MYELOID LEUKEMIA AML CYTOGENETICS PANEL Test is conducted in the CYTOGENETICS department.

Pre Test Information

It is mandatory to fill the Chromosome and FISH analysis Requisition form (Form 17) before undergoing this test.

Test Details

The AML cytogenetics panel test is a diagnostic test used to analyze the genetic abnormalities present in acute myeloid leukemia (AML) cells. AML is a type of cancer that affects the bone marrow and blood, and genetic abnormalities play a crucial role in its development and progression. The panel test typically includes various laboratory techniques such as karyotyping, fluorescence in situ hybridization (FISH), and molecular testing. These techniques help identify specific chromosomal abnormalities and gene mutations associated with AML. The test results provide important information about the genetic profile of the AML cells, which can help guide treatment decisions and predict prognosis. Certain genetic abnormalities, such as the presence of certain gene mutations or chromosomal rearrangements, may indicate a higher or lower risk of treatment response or disease progression. Overall, the AML cytogenetics panel test is an essential tool in the diagnosis and management of AML, as it provides valuable information about the genetic characteristics of the disease.

Test Name ACUTE MYELOID LEUKEMIA AML CYTOGENETICS PANEL Test
Components *t (8;21) or LSI ETO/AML1 * inv (16) (p13q22) or t(16;16) (p13;q22) or CBFB* t (15;17) or LSI PML/RARA*t(variable;11q23) ; MLL gene breakapart*Chromosome analysis, Hematological malignancy
Price 4100.0 AED
Sample Condition 8 mL (6 mL min.) whole bloodfrom 2 Green Top (Sodium Heparin ) tubes AND4 mL (2 mL min.) Bone Marrow from 1 Green Top (Sodium Heparin) tube. Ship at 18-22?\u00f8C. DO NOT FREEZE. Duly filled Chromosome andFISHanalysis Requisition form (Form 17) is mandatory.
Report Delivery Sample Daily by 4 pm; Report 4 Working days
Method FISH & Conventional Karyotyping
Test type Cancer
Doctor Hematologist
Test Department: CYTOGENETICS
Pre Test Information Duly filled Chromosome andFISHanalysis Requisition form (Form 17) is mandatory.
Test Details

The AML cytogenetics panel test is a diagnostic test used to analyze the genetic abnormalities present in acute myeloid leukemia (AML) cells. AML is a type of cancer that affects the bone marrow and blood, and genetic abnormalities play a crucial role in its development and progression.

The panel test typically includes various laboratory techniques such as karyotyping, fluorescence in situ hybridization (FISH), and molecular testing. These techniques help identify specific chromosomal abnormalities and gene mutations associated with AML.

The test results provide important information about the genetic profile of the AML cells, which can help guide treatment decisions and predict prognosis. Certain genetic abnormalities, such as the presence of certain gene mutations or chromosomal rearrangements, may indicate a higher or lower risk of treatment response or disease progression.

Overall, the AML cytogenetics panel test is an essential tool in the diagnosis and management of AML, as it provides valuable information about the genetic characteristics of the disease.

SKU: TEST-4665 Category:

Related products